SCHEMBL23713548

SCHEMBL23713548

CCCCCCc1ccc(-c2cc3ccc(OC)cc3oc2=O)c(CC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ACHE P22303 2/20 0.48
GPR55 Q9Y2T6 2/20 0.47
MAOB P27338 7/20 0.47
MAOA P21397 3/20 0.47
CYP2C19 P33261 1/20 0.47
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALK Q9UM73 1/20 0.44
MAPT P10636 1/20 0.44
CA12 O43570 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CA2 P00918 1/20 0.44
GLA P06280 1/20 0.44
CA3 P07451 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18535678 0.99 NPC1 (0.51) NPC1RAB9AACHEGPR55MAOB
SCHEMBL18554377 0.92 NPC1 (0.51) NPC1RAB9AACHEGPR55MAOB
SCHEMBL23713533 0.89 GLA (0.48) NPC1RAB9AMAOBMAOAKDM4E
SCHEMBL18535674 0.88 MAOB (0.49) NPC1RAB9AACHEGPR55MAOB
SCHEMBL18535477 0.88 NPC1 (0.57) NPC1RAB9AACHEGPR55MAOB
SCHEMBL23316820 0.88 GLA (0.55) NPC1RAB9AMAOBMAOACYP2C19
SCHEMBL24046295 0.88 NPC1 (0.39) NPC1RAB9AACHEGPR55MAOB
SCHEMBL18535535 0.87 MAOB (0.50) NPC1RAB9AACHEGPR55MAOB
SCHEMBL23713532 0.87 THRB (0.40) NPC1RAB9AACHEGPR55MAOB
SCHEMBL20473355 0.86 ALOX5 (0.51) NPC1RAB9AACHEGPR55MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A NPC1 2482/4885RAB9A 930/4885ACHE 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.